<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Lose Weight And Look Great &#187; Weight Loss</title>
	<atom:link href="http://www.loseweightandlookgreat.com/weight-loss/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.loseweightandlookgreat.com</link>
	<description>Good Luck!</description>
	<lastBuildDate>Sat, 26 Aug 2023 18:43:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>Vitamin D in Vietnamese Research Project</title>
		<link>http://www.loseweightandlookgreat.com/vitamin-d-in-vietnamese-research-project/</link>
		<comments>http://www.loseweightandlookgreat.com/vitamin-d-in-vietnamese-research-project/#comments</comments>
		<pubDate>Thu, 25 Apr 2013 16:28:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Weight Loss]]></category>

		<guid isPermaLink="false">http://www.loseweightandlookgreat.com/vitamin-d-in-vietnamese-research-project/</guid>
		<description><![CDATA[<p>A present research project aims to construct on the results of an past find out about which published that Nutrition D deficiency is as excessive as 88% (9 out of 10 people) in Vietnamese residing in Melbourne. Analysis will now examine the effectiveness of Diet D dietary supplements in the treatment of Graves illness for [...]</p><p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/vitamin-d-in-vietnamese-research-project/">Vitamin D in Vietnamese Research Project</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></description>
				<content:encoded><![CDATA[<p>A present research project aims to construct on the results of an past find out about which published that Nutrition D deficiency is as excessive as 88% (9 out of 10 people) in Vietnamese residing in Melbourne. Analysis will now examine the effectiveness of Diet D dietary supplements in the treatment of Graves illness for Vietnamese and determine the genetic background of Graves illness in Vietnamese.</p>
<p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/vitamin-d-in-vietnamese-research-project/">Vitamin D in Vietnamese Research Project</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://www.loseweightandlookgreat.com/vitamin-d-in-vietnamese-research-project/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Migraine and Healthy Eyes Research Project</title>
		<link>http://www.loseweightandlookgreat.com/migraine-and-healthy-eyes-research-project/</link>
		<comments>http://www.loseweightandlookgreat.com/migraine-and-healthy-eyes-research-project/#comments</comments>
		<pubDate>Thu, 25 Apr 2013 16:28:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Weight Loss]]></category>

		<guid isPermaLink="false">http://www.loseweightandlookgreat.com/migraine-and-healthy-eyes-research-project/</guid>
		<description><![CDATA[<p>Volunteers are invited to participate in a research learn about assessing the results ofnbsp;migrainenbsp;headaches on visible perform (HREC#0932638). The find out about will contain up to 3 check periods, each and every of which may take as much as three hours. Right through the periods, the next can be performed:Annbsp;eye examinationnbsp;to decide whether or not [...]</p><p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/migraine-and-healthy-eyes-research-project/">Migraine and Healthy Eyes Research Project</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></description>
				<content:encoded><![CDATA[<p>Volunteers are invited to participate in a research learn about assessing the results ofnbsp;migrainenbsp;headaches on visible perform (HREC#0932638). The find out about will contain up  to 3 check periods, each and every of which may take as much as three hours.  Right through the periods, the next can be performed:Annbsp;eye  examinationnbsp;to decide whether or not you&#8217;re eligible to participate in the  learn about.A sequence of same old medical exams the place you might be  required to reply to goals introduced on your field of view.Electrophysiological  recordings of the indicators coming from thenbsp;eyenbsp;and thenbsp;brai</p>
<p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/migraine-and-healthy-eyes-research-project/">Migraine and Healthy Eyes Research Project</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://www.loseweightandlookgreat.com/migraine-and-healthy-eyes-research-project/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cortical Markers for Glaucoma Research Project</title>
		<link>http://www.loseweightandlookgreat.com/cortical-markers-for-glaucoma-research-project/</link>
		<comments>http://www.loseweightandlookgreat.com/cortical-markers-for-glaucoma-research-project/#comments</comments>
		<pubDate>Thu, 25 Apr 2013 16:28:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Weight Loss]]></category>

		<guid isPermaLink="false">http://www.loseweightandlookgreat.com/cortical-markers-for-glaucoma-research-project/</guid>
		<description><![CDATA[<p>Volunteers are needed for a research study into the results of glaucoma on the mind. They&#8217;ll require two appointments in total. Any such might be at the Royal Victorian Eye and Ear Clinic, East Melbourne, the place they will have a full eye examination and a few imaging of the again of the eye. The [...]</p><p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/cortical-markers-for-glaucoma-research-project/">Cortical Markers for Glaucoma Research Project</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></description>
				<content:encoded><![CDATA[<p>Volunteers are needed for a research study into the results of glaucoma on the mind.<br />
They&#8217;ll require two appointments in total. Any such might be at the Royal Victorian Eye and Ear Clinic, East Melbourne, the place they will have a full eye examination and a few imaging of the again of the eye. The 2nd appointment will likely be on the Mind Analysis Institute located at the Austin Repatriation Medical institution, Heidelberg, the place they&#8217;ll have an MRI scan.</p>
<p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/cortical-markers-for-glaucoma-research-project/">Cortical Markers for Glaucoma Research Project</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://www.loseweightandlookgreat.com/cortical-markers-for-glaucoma-research-project/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients with Moderate to Severe Active Rheumatoid Arthritis</title>
		<link>http://www.loseweightandlookgreat.com/a-study-to-compare-subcutaneous-versus-intravenous-administration-of-roactemraactemra-tocilizumab-in-patients-with-moderate-to-severe-active-rheumatoid-arthritis/</link>
		<comments>http://www.loseweightandlookgreat.com/a-study-to-compare-subcutaneous-versus-intravenous-administration-of-roactemraactemra-tocilizumab-in-patients-with-moderate-to-severe-active-rheumatoid-arthritis/#comments</comments>
		<pubDate>Thu, 25 Apr 2013 16:28:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Weight Loss]]></category>

		<guid isPermaLink="false">http://www.loseweightandlookgreat.com/a-study-to-compare-subcutaneous-versus-intravenous-administration-of-roactemraactemra-tocilizumab-in-patients-with-moderate-to-severe-active-rheumatoid-arthritis/</guid>
		<description><![CDATA[<p>This randomised, double-blind, parallel workforce learn about will examine the efficacy and safety of subcutaneous (sc) versus intravenous (iv) administration of RoActemra/Actemra (tocilizumab) in patients with moderate to extreme active rheumatoid arthritis. Patients will likely be randomised to receive either RoActemra/Actemra 162 mg sc weekly plus iv placebo every four weeks, or RoActemra/Actemra eight mg/kg [...]</p><p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/a-study-to-compare-subcutaneous-versus-intravenous-administration-of-roactemraactemra-tocilizumab-in-patients-with-moderate-to-severe-active-rheumatoid-arthritis/">A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients with Moderate to Severe Active Rheumatoid Arthritis</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></description>
				<content:encoded><![CDATA[<p>This randomised, double-blind, parallel workforce learn about will examine the efficacy and safety of subcutaneous (sc) versus intravenous (iv) administration of RoActemra/Actemra (tocilizumab) in patients with moderate to extreme active rheumatoid arthritis. Patients will likely be randomised to receive either RoActemra/Actemra 162 mg sc weekly plus iv placebo every four weeks, or RoActemra/Actemra eight mg/kg iv every 4 weeks plus sc placebo weekly throughout the double-blind duration from baseline to Week 24. The double-blind period will probably be followed via a 72-week open-label therapy with some switching of sc and iv admin</p>
<p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/a-study-to-compare-subcutaneous-versus-intravenous-administration-of-roactemraactemra-tocilizumab-in-patients-with-moderate-to-severe-active-rheumatoid-arthritis/">A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients with Moderate to Severe Active Rheumatoid Arthritis</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://www.loseweightandlookgreat.com/a-study-to-compare-subcutaneous-versus-intravenous-administration-of-roactemraactemra-tocilizumab-in-patients-with-moderate-to-severe-active-rheumatoid-arthritis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A Study of LY2127399 in Patients with Systemic Lupus Erythematosus</title>
		<link>http://www.loseweightandlookgreat.com/a-study-of-ly2127399-in-patients-with-systemic-lupus-erythematosus/</link>
		<comments>http://www.loseweightandlookgreat.com/a-study-of-ly2127399-in-patients-with-systemic-lupus-erythematosus/#comments</comments>
		<pubDate>Thu, 25 Apr 2013 16:28:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Weight Loss]]></category>

		<guid isPermaLink="false">http://www.loseweightandlookgreat.com/a-study-of-ly2127399-in-patients-with-systemic-lupus-erythematosus/</guid>
		<description><![CDATA[<p>The aim of this SLE study is to judge the efficacy, safety and tolerability of two different doses of LY2127399 administered along with same old of care treatment in patients with lively SLE.</p><p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/a-study-of-ly2127399-in-patients-with-systemic-lupus-erythematosus/">A Study of LY2127399 in Patients with Systemic Lupus Erythematosus</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></description>
				<content:encoded><![CDATA[<p>The aim of this SLE study is to judge the efficacy, safety and tolerability of two different doses of LY2127399 administered along with same old of care treatment in patients with lively SLE.</p>
<p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/a-study-of-ly2127399-in-patients-with-systemic-lupus-erythematosus/">A Study of LY2127399 in Patients with Systemic Lupus Erythematosus</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://www.loseweightandlookgreat.com/a-study-of-ly2127399-in-patients-with-systemic-lupus-erythematosus/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects with Autosomal Dominant Polycystic Kidney Disease</title>
		<link>http://www.loseweightandlookgreat.com/study-to-evaluate-the-long-term-efficacy-and-safety-of-oral-tolvaptan-tablet-regimens-in-subjects-with-autosomal-dominant-polycystic-kidney-disease/</link>
		<comments>http://www.loseweightandlookgreat.com/study-to-evaluate-the-long-term-efficacy-and-safety-of-oral-tolvaptan-tablet-regimens-in-subjects-with-autosomal-dominant-polycystic-kidney-disease/#comments</comments>
		<pubDate>Thu, 25 Apr 2013 16:28:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Weight Loss]]></category>

		<guid isPermaLink="false">http://www.loseweightandlookgreat.com/study-to-evaluate-the-long-term-efficacy-and-safety-of-oral-tolvaptan-tablet-regimens-in-subjects-with-autosomal-dominant-polycystic-kidney-disease/</guid>
		<description><![CDATA[<p>To demonstrate whether or not tolvaptan modifies ADPKD development as measured via adjustments from baseline (from trial 156-04-251) in whole kidney extent (TKV) and renal function.</p><p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/study-to-evaluate-the-long-term-efficacy-and-safety-of-oral-tolvaptan-tablet-regimens-in-subjects-with-autosomal-dominant-polycystic-kidney-disease/">Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects with Autosomal Dominant Polycystic Kidney Disease</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></description>
				<content:encoded><![CDATA[<p>To demonstrate whether or not tolvaptan modifies ADPKD development as measured via adjustments from baseline (from trial 156-04-251) in whole kidney extent (TKV) and renal function.</p>
<p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/study-to-evaluate-the-long-term-efficacy-and-safety-of-oral-tolvaptan-tablet-regimens-in-subjects-with-autosomal-dominant-polycystic-kidney-disease/">Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects with Autosomal Dominant Polycystic Kidney Disease</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://www.loseweightandlookgreat.com/study-to-evaluate-the-long-term-efficacy-and-safety-of-oral-tolvaptan-tablet-regimens-in-subjects-with-autosomal-dominant-polycystic-kidney-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nasal Application of 5% Tea Tree Oil (TTO) Versus Mupirocin for the Prevention of Catheter-associated Infections in Renal Dialysis Patients</title>
		<link>http://www.loseweightandlookgreat.com/nasal-application-of-5-tea-tree-oil-tto-versus-mupirocin-for-the-prevention-of-catheter-associated-infections-in-renal-dialysis-patients/</link>
		<comments>http://www.loseweightandlookgreat.com/nasal-application-of-5-tea-tree-oil-tto-versus-mupirocin-for-the-prevention-of-catheter-associated-infections-in-renal-dialysis-patients/#comments</comments>
		<pubDate>Thu, 25 Apr 2013 16:28:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Weight Loss]]></category>

		<guid isPermaLink="false">http://www.loseweightandlookgreat.com/nasal-application-of-5-tea-tree-oil-tto-versus-mupirocin-for-the-prevention-of-catheter-associated-infections-in-renal-dialysis-patients/</guid>
		<description><![CDATA[<p>This learn about will evaluate the use of tea tree oil towards mupirocin as a topical nasal antiseptic to look which is very best at fighting infections in patients that want renal dialysis. Fifty topics will probably be recruited into each and every arm of the trial and can be assessed for indicators of infection [...]</p><p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/nasal-application-of-5-tea-tree-oil-tto-versus-mupirocin-for-the-prevention-of-catheter-associated-infections-in-renal-dialysis-patients/">Nasal Application of 5% Tea Tree Oil (TTO) Versus Mupirocin for the Prevention of Catheter-associated Infections in Renal Dialysis Patients</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></description>
				<content:encoded><![CDATA[<p>This learn about will evaluate the use of tea tree oil towards mupirocin as a topical nasal antiseptic to look which is very best at fighting infections in patients that want renal dialysis. Fifty topics will probably be recruited into each and every arm of the trial and can be assessed for indicators of infection once per week for the primary 6 weeks and then each 4 weeks except week 26. They will even be checked for nasal carriage of Golden Staph once they sign up within the trial. The topics will complete the trial if they have got 26 weeks infection-free or if they have an infection during that length.</p>
<p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/nasal-application-of-5-tea-tree-oil-tto-versus-mupirocin-for-the-prevention-of-catheter-associated-infections-in-renal-dialysis-patients/">Nasal Application of 5% Tea Tree Oil (TTO) Versus Mupirocin for the Prevention of Catheter-associated Infections in Renal Dialysis Patients</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://www.loseweightandlookgreat.com/nasal-application-of-5-tea-tree-oil-tto-versus-mupirocin-for-the-prevention-of-catheter-associated-infections-in-renal-dialysis-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Metabolic Phenotyping of Individuals Born Following Assisted Reproduction Techniques (IMPART)</title>
		<link>http://www.loseweightandlookgreat.com/metabolic-phenotyping-of-individuals-born-following-assisted-reproduction-techniques-impart/</link>
		<comments>http://www.loseweightandlookgreat.com/metabolic-phenotyping-of-individuals-born-following-assisted-reproduction-techniques-impart/#comments</comments>
		<pubDate>Thu, 25 Apr 2013 16:28:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Weight Loss]]></category>

		<guid isPermaLink="false">http://www.loseweightandlookgreat.com/metabolic-phenotyping-of-individuals-born-following-assisted-reproduction-techniques-impart/</guid>
		<description><![CDATA[<p>This learn about is to match the consequences of high-fats overfeeding on metabolic risk components in children born through assisted copy applied sciences (ART) versus youngsters conceived naturally (controls). We will utilise state-of-the-art measures to characterise the physiological, endocrine and molecular responses to high fat overfeeding. The investigators hypothesise that children conceived following ART can [...]</p><p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/metabolic-phenotyping-of-individuals-born-following-assisted-reproduction-techniques-impart/">Metabolic Phenotyping of Individuals Born Following Assisted Reproduction Techniques (IMPART)</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></description>
				<content:encoded><![CDATA[<p>This learn about is to match the consequences of high-fats overfeeding on metabolic risk components in children born through assisted copy applied sciences (ART) versus youngsters conceived naturally (controls). We will utilise state-of-the-art measures to characterise the physiological, endocrine and molecular responses to high fat overfeeding.<br />
The investigators hypothesise that children conceived following ART can have greater responses to excessive-fats dietary challenge and that this can be related to DNA hypermethylation of genes that are enthusiastic about lipid metabolism.</p>
<p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/metabolic-phenotyping-of-individuals-born-following-assisted-reproduction-techniques-impart/">Metabolic Phenotyping of Individuals Born Following Assisted Reproduction Techniques (IMPART)</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://www.loseweightandlookgreat.com/metabolic-phenotyping-of-individuals-born-following-assisted-reproduction-techniques-impart/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CAROLINA: Cardiovascular Outcome Study of Linagliptin versus Glimepiride in Patients with Type 2 Diabetes</title>
		<link>http://www.loseweightandlookgreat.com/carolina-cardiovascular-outcome-study-of-linagliptin-versus-glimepiride-in-patients-with-type-2-diabetes/</link>
		<comments>http://www.loseweightandlookgreat.com/carolina-cardiovascular-outcome-study-of-linagliptin-versus-glimepiride-in-patients-with-type-2-diabetes/#comments</comments>
		<pubDate>Thu, 25 Apr 2013 16:28:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Weight Loss]]></category>

		<guid isPermaLink="false">http://www.loseweightandlookgreat.com/carolina-cardiovascular-outcome-study-of-linagliptin-versus-glimepiride-in-patients-with-type-2-diabetes/</guid>
		<description><![CDATA[<p>The aim of the study is to investigate the lengthy-time period influence on cardiovascular morbidity and mortality, relevant efficacy parameters (e.g., glycaemic parameters) and security (e.g., weight and hypoglycaemia) of remedy with linagliptin in patients with kind-2 diabetes at multiplied cardiovascular chance receiving general care, and evaluate outcome towards glimepiride.</p><p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/carolina-cardiovascular-outcome-study-of-linagliptin-versus-glimepiride-in-patients-with-type-2-diabetes/">CAROLINA: Cardiovascular Outcome Study of Linagliptin versus Glimepiride in Patients with Type 2 Diabetes</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></description>
				<content:encoded><![CDATA[<p>The aim of the study is to investigate the lengthy-time period influence on cardiovascular morbidity and mortality, relevant efficacy parameters (e.g., glycaemic parameters) and security (e.g., weight and hypoglycaemia) of remedy with linagliptin in patients with kind-2 diabetes at multiplied cardiovascular chance receiving general care, and evaluate outcome towards glimepiride.</p>
<p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/carolina-cardiovascular-outcome-study-of-linagliptin-versus-glimepiride-in-patients-with-type-2-diabetes/">CAROLINA: Cardiovascular Outcome Study of Linagliptin versus Glimepiride in Patients with Type 2 Diabetes</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://www.loseweightandlookgreat.com/carolina-cardiovascular-outcome-study-of-linagliptin-versus-glimepiride-in-patients-with-type-2-diabetes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Safety Evaluation of the GSK-580299 Vaccine in Women from the Control Group in the Primary NCT00294047 Study</title>
		<link>http://www.loseweightandlookgreat.com/the-safety-evaluation-of-the-gsk-580299-vaccine-in-women-from-the-control-group-in-the-primary-nct00294047-study/</link>
		<comments>http://www.loseweightandlookgreat.com/the-safety-evaluation-of-the-gsk-580299-vaccine-in-women-from-the-control-group-in-the-primary-nct00294047-study/#comments</comments>
		<pubDate>Thu, 25 Apr 2013 16:28:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Weight Loss]]></category>

		<guid isPermaLink="false">http://www.loseweightandlookgreat.com/the-safety-evaluation-of-the-gsk-580299-vaccine-in-women-from-the-control-group-in-the-primary-nct00294047-study/</guid>
		<description><![CDATA[<p>This extension learn about is designed to investigate the safety of GSK Biologicals HPV vaccine GSK580299 in feminine subjects who took phase in the primary find out about NCT00294047 and acquired the regulate vaccine in countries for which the licensed GSK HPV vaccine just isn&#8217;t indicated for the topics age team (26 years and older). [...]</p><p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/the-safety-evaluation-of-the-gsk-580299-vaccine-in-women-from-the-control-group-in-the-primary-nct00294047-study/">The Safety Evaluation of the GSK-580299 Vaccine in Women from the Control Group in the Primary NCT00294047 Study</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></description>
				<content:encoded><![CDATA[<p>This extension learn about is designed to investigate the safety of GSK Biologicals HPV vaccine GSK580299 in feminine subjects who took phase in the primary find out about NCT00294047 and acquired the regulate vaccine in countries for which the licensed GSK HPV vaccine just isn&#8217;t indicated for the topics age team (26 years and older). This learn about is therefore conducted to allow all girls who got the regulate placebo in the main NCT00294047 study to receive the GSK580299 vaccine.</p>
<p>The post <a rel="nofollow" href="http://www.loseweightandlookgreat.com/the-safety-evaluation-of-the-gsk-580299-vaccine-in-women-from-the-control-group-in-the-primary-nct00294047-study/">The Safety Evaluation of the GSK-580299 Vaccine in Women from the Control Group in the Primary NCT00294047 Study</a> appeared first on <a rel="nofollow" href="http://www.loseweightandlookgreat.com">Lose Weight And Look Great</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://www.loseweightandlookgreat.com/the-safety-evaluation-of-the-gsk-580299-vaccine-in-women-from-the-control-group-in-the-primary-nct00294047-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
